Travoprost: how does it work?

Article

Travoprost appears to lower intraocular pressure (IOP) by increasing trabecular outflow facility, although an effect on uvoescleral outflow cannot be ruled out, according to a study published in the March issue of the Journal of Glaucoma.

Travoprost appears to lower intraocular pressure (IOP) by increasing trabecular outflow facility, although an effect on uvoescleral outflow cannot be ruled out, according to a study published in the March issue of the Journal of Glaucoma.

Carol Toris and colleagues from the University of Nebraska Medical Center, USA, conducted a study to determine the mechanism by which travoprost 0.004% reduces IOP in patients with ocular hypertension or primary open angle glaucoma. The randomized, double-masked, placebo-controlled, single centre study enrolled 26 subjects.

After a washout of all medications, baseline IOPs were recorded and travoprost 0.004% was administered once-daily in the evening for 17 consecutive days to one eye and its vehicle to the fellow eye in a randomized, masked fashion. On day 15, twelve hours after the 14th dose, IOP was measured by pneumatonometry, aqueous flow and outflow facility by fluorophotometry and episcleral venous pressure by venomanometry. Uveoscleral outflow was determined by mathematical calculation. Two days later, the last drop was administered and fluorophotometry and tonometry measurements were repeated.

Eyes treated with travoprost demonstrated a significant decrease in daytime IOP (p<0.001) compared with baseline (26%) or to vehicle-treated eyes (22%), in addition to an increase in daytime outflow facility (p=0.001; 64%). The increase in uveoscleral outflow was not statistically significant. At night, travoprost-treated eyes remained 21-24% below baseline daytime values. Aqueous outflow was significantly reduced at night (p<0.001) in both travoprost (30%) and vehicle-treated eyes (25%) when compared with daytime values.

The researchers believe that travoprost works by increasing trabecular outflow facility, however, an effect on uveoscleral outflow cannot be ruled out.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Related Content
© 2025 MJH Life Sciences

All rights reserved.